
Prescription Drug Name:
TRIAMCINOLONE ACETONIDE 15G
ID:
4a41d462-748c-40f1-8fd6-c000959a00cd
Code:
34391-3
DESCRIPTION
id: c5d9fdf7-2e2b-411d-b497-384834ac434b
displayName: DESCRIPTION SECTION
FDA Article Code: 34089-3
Each gram of Triamcinolone Acetonide Cream USP, 0.1 % contains 1 mg triamcinolone acetonide USP in a cream base consisting of purified water, emulsifying wax, mineral oil, propylene glycol, sorbitol solution, cetyl palmitate, sorbic acid, and potassium sorbate.
Each gram of Triamcinolone Acetonide Cream USP, 0.5 % contains 5 mg triamcinolone acetonide USP in a cream base consisting of purified water, emulsifying wax, mineral oil, propylene glycol, sorbitol solution, cetyl palmitate, sorbic acid, and potassium sorbate.
CLINICAL PHARMACOLOGY
id: 7dbfef95-af7d-426f-bbc8-05d5a36c32ed
displayName: CLINICAL PHARMACOLOGY SECTION
FDA Article Code: 34090-1
The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict potencies and/or clinical efficacies of the topical corticosteroids. There is some evidence to suggest that a recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in man.
Pharmacokinetics
The extent of percutaneous absorption of topical corticosteroids is determined by many factors including the vehicle, the integrity of the epidermal barrier, and the use of occlusive dressings.
Topical corticosteroids can be absorbed from normal intact skin. Inflammation and/or other disease processes in the skin increase percutaneous absorption. Occlusive dressings substantially increase the percutaneous absorption of topical corticosteroids. Thus, occlusive dressings may be a valuable therapeutic adjunct for treatment of resistant dermatoses. (See
Once absorbed through the skin, topical corticosteroids are handled through pharmacokinetic pathways similar to systemically administered corticosteroids. Corticosteroids are bound to plasma proteins in varying degrees. Corticosteriods are metabolized primarily in the liver and are then excreted by the kidneys. Some of the topical corticosteroids and their metabolites are also excreted into the bile.
INDICATIONS & USAGE
id: a0034fe8-a825-40bd-a816-a266044775c4
displayName: INDICATIONS & USAGE SECTION
FDA Article Code: 34067-9
CONTRAINDICATIONS
id: ba9f5b30-2eca-4d31-a33d-1830a38f44ec
displayName: CONTRAINDICATIONS SECTION
FDA Article Code: 34070-3
ADVERSE REACTIONS
id: 19e8c287-b9d3-4186-82f4-d1cefc2c17f8
displayName: ADVERSE REACTIONS SECTION
FDA Article Code: 34084-4
Burning
Itching
Irritation
Dryness
Folliculitis
Hypertrichosis
Acneiform eruptions
Hypopigmentation
Perioral dermatitis
Allergic contact dermatitis
Maceration of the skin
Secondary infection
Skin Atrophy
Striae
Miliaria
OVERDOSAGE
id: d6ebff3c-5c5a-4729-941d-93987e96a9d7
displayName: OVERDOSAGE SECTION
FDA Article Code: 34088-5
DOSAGE & ADMINISTRATION
id: 664ead24-3746-43cf-8684-aa77f0b09cb7
displayName: DOSAGE & ADMINISTRATION SECTION
FDA Article Code: 34068-7
Occlusive dressing may be used for the management of psoriasis or recalcitrant conditions.
If an infection develops, the use of occlusive dressing should be discontinued and appropriate antimicrobial therapy instituted.
HOW SUPPLIED
id: 4417846b-7eef-4b37-8d00-dec014fc2fd4
displayName: HOW SUPPLIED SECTION
FDA Article Code: 34069-5
30 GRAM in a TUBE (0440-0251-30) | |
45 GRAM in a JAR (0440-0251-45) | |
80 GRAM in a TUBE (0440-0251-80) | |
15 GRAM in a TUBE (0440-0251-15) |
Avoid excessive heat. Protect from freezing.
PRINTED IN USA
Packaged by: AIDAREX PHARMACEUTICALS LLC.
Revised: 07/2016
PACKAGE LABEL. PRINCIPAL DISPLAY PANEL
id: ee1c5544-10ec-4633-a7ac-8e5cf13a59fd
displayName: PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA Article Code: 51945-4
PACKAGE LABEL. PRINCIPAL DISPLAY PANEL
id: 77f77b73-82af-433e-a51e-d3365d2b77bd
displayName: PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA Article Code: 51945-4
PACKAGE LABEL. PRINCIPAL DISPLAY PANEL
id: c73b051d-13e4-499a-80b1-2a15354c32dc
displayName: PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA Article Code: 51945-4
PACKAGE LABEL. PRINCIPAL DISPLAY PANEL
id: 5ce3e310-5370-4867-b10b-ddfd4a49a72d
displayName: PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
FDA Article Code: 51945-4